Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Exposure to antidepressant and antipsychotic medicines in pregnant women and risk of gestational diabetes: a systematic review and meta-analysis of observational studies

AI Summary
  • Prenatal exposure to antipsychotics and antidepressants increases gestational diabetes risk; pooled adjusted RRs approximately 1.43 for antipsychotics and 1.19 for antidepressants.
  • Second-generation antipsychotics carry a markedly higher GDM risk (RR 1.60, 95% CI 1.23 to 1.97); first-generation antipsychotics not significantly associated.
  • Clinicians should weigh these risks when prescribing psychotropics in pregnancy and ensure appropriate metabolic monitoring.
Summarise with AI (MRCPsych/FRANZCP)

Arch Womens Ment Health. 2026 Oct 26;29(6):143. doi: 10.1007/s00737-026-01733-y.

ABSTRACT

BACKGROUND: Antidepressants and antipsychotics are commonly prescribed for psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder, and severe anxiety disorders. Psychotropic medications are increasingly prescribed during pregnancy to manage severe mental illnesses. Concerns have been raised about their metabolic side effects, including the risk of gestational diabetes mellitus (GDM). This study aimed to systematically review and meta-analyze existing evidence on the risk of GDM development in pregnant women with prenatal exposure to two common psychotropics, antipsychotics and antidepressants.

METHODS: We conducted a systematic search of PubMed, Scopus, and the Web of Science, up to June 2025, identifying observational studies reporting GDM outcomes following the use of psychotropic medicines during pregnancy. Eligible studies were reviewed, and pooled relative risks (RRs) were calculated using a random-effects model, with subgroup analyses based on medication classification.

RESULTS: Twenty-one studies were included in this review and meta-analysis. The pooled adjusted RR for GDM among women exposed to any antipsychotics and antidepressants during pregnancy was 1.43 (95% CI: 1.17,1.69), and 1.19 (95% CI: 1.10,1.27). Second-generation antipsychotics (SGAs) were associated with a significantly higher risk of GDM (RR = 1.6, 95% CI: 1.23, 1.97). First-generation antipsychotics showed no statistically significant association.

CONCLUSIONS: Prenatal exposure to antipsychotics, particularly SGAs, and antidepressants is associated with an increased risk of GDM. Clinicians should consider these risks when prescribing psychotropic medications during pregnancy and ensure appropriate metabolic monitoring.

PMID:42931956 | DOI:10.1007/s00737-026-01733-y

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD